Search Results
Aug 05, 2026, 12:15 ET GenScript and Tamarind Bio Partner to Connect AI Molecular Design with Rapid Lab Validation
www.genscript.com.About Tamarind BioTamarind Bio, founded in 2023 in San Francisco, is a unified interface to 300+ molecular AI/ML tools for drug discovery. Tamarind provides scientists with a no-code web interface, AI agent or API to access leading molecular design workflows, including
More news about: GenScript Biotech Corporation
Aug 05, 2026, 12:15 ET GenScript and Tamarind Bio Partner to Connect AI Molecular Design with Rapid Lab Validation
www.genscript.com.About Tamarind BioTamarind Bio, founded in 2023 in San Francisco, is a unified interface to 300+ molecular AI/ML tools for drug discovery. Tamarind provides scientists with a no-code web interface, AI agent or API to access leading molecular design workflows, including
More news about: GenScript Biotech Corporation
Aug 05, 2026, 10:15 ET VCSEL Market worth $1.96 billion by 2032 - Exclusive Report by MarketsandMarkets™
acquisition strengthened Lumentum's optical module portfolio and expanded its capabilities in high-speed data center connectivity, particularly for AI and ML workloads. The transaction reflects the broader focus of VCSEL market participants on acquiring complementary optical technologies and capabilities to
More news about: MarketsandMarkets
Aug 05, 2026, 09:52 ET Biointron Launches RushData, an Integrated High-Throughput Platform for AI-Driven Antibody Discovery
1-day CHO expression for data generation in days, not weeks, for standardized, structured datasets ready for AI/ML-driven designCustom workflows for targets and modalities, with 3,000+ molecules per batch processed in parallelIdentify liabilities early with developability
More news about: Biointron
Aug 05, 2026, 09:02 ET Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq 67Cu-SAR-bisPSMA dose level with two additional complete responses
radiographic assessment treated at the 8 GBq 67Cu-SAR-bisPSMA dose level.The median baseline PSA among these seven participants was 90.3 ng/mL (range 3.3 – 490.3). They had received a median of 5 prior anti-cancer regimens (range 4-7). Bone metastases were present in four of seven participants
More news about: Clarity Pharmaceuticals
Aug 05, 2026, 08:05 ET Accord Healthcare Launches Sugammadex Injection, Expanding Access to Neuromuscular Blockade Reversal During Surgery
Sugammadex Injection is available in 200 mg/2 mL and 500 mg/5 mL single-dose vials for intravenous administration.The addition of Sugammadex Injection expands Accord Healthcare's portfolio and reinforces
More news about: Accord Healthcare US
Aug 04, 2026, 16:05 ET Teradata Reports Second Quarter 2026 Financial Results
ongoing business transformation, significant execution risk for our cloud, hybrid, on-premises, Artificial Intelligence ("AI") and Machine Learning ("ML") offerings, operational disruptions and unforeseen circumstances, impact of unanticipated delays or acceleration in our sales cycles to make accurate
More news about: Teradata
Aug 04, 2026, 09:05 ET MINUTE MAID SPIKED® EXPANDS ITS PORTFOLIO WITH THE LAUNCH OF VODKA LEMONADE ICED TEA
cocktails in the following flavors: Lime Margarita, Strawberry Daiquiri, Piña Colada, and Blue Hawaiian - available in 1.5L glass bottles, 750ml PET bottles, and 200ml "ready-to-drink" mini cans. The brand also includes other vodka-based ARTD offerings, including Vodka Lemonade (Classic and Pink) and Vodka
More news about: Red Tree Beverages
Aug 04, 2026, 09:02 ET J. Lohr Unveils a Fresh New Look for its 2025 Flume Crossing Sauvignon Blanc
commitment to protecting natural resources while crafting wines that authentically express their vineyard origins.In addition to its beautiful new 750ml package, Flume Crossing is also available to on-premise accounts "on tap" as part of J. Lohr's innovative, reusable stainless steel keg program. J. Lohr
More news about: Colangelo & Partners Public Relations
Aug 04, 2026, 09:00 ET Gurucul Previews Security for AI with Runtime Detection and Response, and Launches Advanced AI-Assisted Data Pipelines to Support a Cost-Optimized, Vendor-Neutral Data Fabric
does.Gurucul fuses these detection modalities together in our Relational Graph, leveraging endpoint, proxy, network and CASB signals alongside ML-driven baselining to validate the risk and provide deep evidence and context as the risk is forming. This enables analysts and agents, with purpose-built
More news about: Gurucul
Aug 04, 2026, 08:00 ET Alif Semiconductor Licenses Arm Keil MDK to Accelerate Edge AI Development on Ensemble and Balletto Devices
effort, Alif and Arm are collaborating around the Synchronous Data Stream (SDS) Framework, which streamlines the development of DSP algorithms, ML models, and edge AI applications that process periodic data streams, including sensor, audio, and video inputs. SDS enables developers to record and
More news about: Alif Semiconductor
Aug 04, 2026, 07:05 ET Alpha Omega Expands Its Awardable Continuum Portfolio on the CDAO's Tradewinds Solutions Marketplace
premier offering of Tradewinds, the Department of War's (DoW's) suite of tools and services designed to accelerate the procurement and adoption of AI/ML, data, and analytics capabilities.With three Continuum accelerators now assessed as Awardable, DoW customers can find, evaluate, and award capabilities
More news about: Alpha Omega
Aug 04, 2026, 07:00 ET Marengo Nominates First Drug Candidate Under Strategic TriSTAR Collaboration with Ipsen and Welcomes Industry-Leading T-Cell Engager Expert, Saso Cemerski, Ph.D., to Accelerate Pipeline Expansion
ristar-collaboration-with-ipsen-and-welcomes-industry-leading-t-cell-engager-expert-saso-cemerski-phd-to-accelerate-pipeline-expansion-302841465.htmlSOURCE Marengo Therapeutics
More news about: Marengo Therapeutics
Aug 03, 2026, 10:31 ET Dementia-related Psychosis Market Gearing Up for Outstanding Expansion at a CAGR of 26.2% During the Forecast Period (2026-2036) | DelveInsight
dementia-related psychosis therapies in clinical trials include ACP-204 (Remlifanserin), Xanomeline–trospium chloride (COBENFY), Zervimesine (CT1812), ML-007C-MA, ITI-1284, Levetiracetam low-dose (AGB101), and others.Discover dementia-related psychosis new treatment @
More news about: DelveInsight Business Research, LLP
Aug 03, 2026, 08:58 ET Sanctions Lifted, Life Hasn't Improved: RTVI Field Report Documents Syria's Struggles After Assad's Fall
https://youtu.be/F8wOMF-INC0?si=m2TZLsPU4Ml-vFwkAbout RTVIRTVI is a leading international multiplatform Russian-language media outlet, broadcasting to audiences
More news about: RTVI
Aug 03, 2026, 08:00 ET Rebuild Hollow Undereyes by 129%* with Smart Eye Density
corner under the eye and moving outward toward the temple. Use twice daily.AvailabilitySmart Eye Density comes in a 0.5 FL OZ / 15 mL airless pump bottle and will be available beginning August 3, 2026 at Dermalogica flagship locations, on dermalogica.com, and through authorized
More news about: Dermalogica
Aug 03, 2026, 07:04 ET Delta Development Team's DoW Cold Chain Logistics Solution Assessed "Awardable" in Tradewinds Solutions Marketplace
readily awardable pitch videos that address the Department of War's (DoW's) most significant challenges in the Artificial Intelligence/Machine Learning (AI/ML), data, and analytics space. All awardable solutions have been assessed through complex scoring rubrics and competitive procedures and are available
More news about: Delta Development Team
Aug 03, 2026, 07:00 ET Compugen Reports Second Quarter 2026 Results
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today reported financial results for the second quarter of 2026 and provided a corporate update. "Q2 2026 reflects continued execution across
More news about: Compugen Ltd.
Aug 02, 2026, 23:18 ET MOYOM fait progresser l'esthétique régénérative en Europe grâce à la certification APHRANEL® conforme au règlement MDR de l'UE et à une collaboration scientifique stratégique avec Expert2Expert
-grace-a-la-certification-aphranel-conforme-au-reglement-mdr-de-lue-et-a-une-collaboration-scientifique-strategique-avec-expert2expert-302840800.html
More news about: Aphranel®
Jul 31, 2026, 14:48 ET American Regent, Inc. Animal Health Issues Nationwide Recall of two lots of Adequan® Canine and two lots of Adequan® i.m. due to visible glass fiber material in the product
of two lots (25011 and 3369) of Adequan® Canine Injection (for dogs), 100 mg/mL 5 mL multi-dose vials and two lots (24416 and 25265P) of Adequan® i.m. Injection (for horses), 500 mg/5 mL single-dose 5 mL vials to the consumer level. The products are being recalled due to the presence of
More news about: American Regent, Inc.
Jul 31, 2026, 12:20 ET KLADNÉ STANOVISKO CHMP PODPORUJE ŠIRŠÍ POUŽITÍ PŘÍPRAVKU REPATHA® SPOLEČNOSTI AMGEN PŘED PRVNÍM INFARKTEM NEBO MOZKOVOU MRTVICÍ
látek.Zvláštní varování a opatření: Porucha funkce ledvin: Pacienti s těžkou poruchou funkce ledvin (definovanou jako eGFR < 30 ml/min/1,73 m2) nebyli ve studii hodnoceni. Přípravek Repatha by měl být u pacientů s těžkou poruchou funkce ledvin používán s opatrností. Porucha
More news about: Amgen
Jul 31, 2026, 10:01 ET Generative AI Market worth $1,658.97 billion by 2033 - Report by MarketsandMarkets™
Artificial Intelligence (AI) Market by Offering [Hardware (AI Chips, Memory, Storage), Software, Services], Technology (ML, NLP, Generative AI, Neurosymbolic AI), Business Function (Operations & Supply Chain, Sales & Marketing) - Global Forecast to 2033
More news about: MarketsandMarkets
Jul 30, 2026, 13:07 ET POSITIVE STELLUNGNAHME DES CHMP UNTERSTÜTZT BREITERE ANWENDUNG VON AMGENS REPATHA® VOR ERSTEM HERZINFARKT ODER SCHLAGANFALL
Warnhinweise und Vorsichtsmaßnahmen: Nierenfunktionsstörung: Patientinnen und Patienten mit schwerer Nierenfunktionsstörung (definiert als eGFR < 30 ml/min/1,73 m2) wurden nicht untersucht. Repatha sollte bei Patientinnen und Patienten mit schwerer Nierenfunktionsstörung mit Vorsicht angewendet
More news about: Amgen
Jul 30, 2026, 12:45 ET AVIS FAVORABLE DU CMUH CONCERNANT UNE UTILISATION PLUS LARGE DE REPATHA® D'AMGEN POUR REDUIRE LES RISQUES DE PREMIER INFARCTUS DU MYOCARDE OU D'AVC
d'emploi : Insuffisance rénale : aucune étude n'a été menée chez les patients présentant une insuffisance rénale sévère (définie par un eGFR < 30 mL/min/1,73 m2). Repatha doit être utilisé avec prudence chez les patients présentant une insuffisance rénale sévère. Insuffisance hépatique : chez
More news about: Amgen
Jul 30, 2026, 12:40 ET Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application, the company launched Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vial in the United States.
More news about: Lupin Pharmaceuticals, Inc.